Inactive Instrument
Isodiol International Inc Share Price Canadian Securities Exchange
Stocks
CA46500L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.84M 2.43M 2.28M 2.08M 272M 3.96M 26.9M 10.49M 137M 10.67M 10.43M 452M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.63M 5.68M 5.32M 4.87M 635M 9.25M 62.81M 24.5M 319M 24.91M 24.37M 1.05B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -3.58% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 23/05/2017 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 29/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 23/05/2017 |
| Director/Board Member | - | 29/08/2018 | |
| Director/Board Member | - | 20/11/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.58% | +881.08% | - | - | 128 | |
| -1.75% | -1.40% | -14.42% | -5.80% | 13.09B | |
| -2.74% | -2.90% | -35.91% | -58.08% | 4.85B | |
| -6.30% | -6.88% | -7.32% | -6.01% | 4.59B | |
| -5.35% | -3.01% | +1.29% | -26.92% | 4.09B | |
| -2.56% | -2.27% | -24.04% | +2.40% | 3.51B | |
| -2.87% | -0.49% | -11.37% | -6.48% | 3.34B | |
| -3.23% | -2.35% | -12.30% | +13.41% | 3.33B | |
| -4.14% | -2.45% | -18.19% | -14.63% | 2.43B | |
| -3.92% | -3.50% | -30.34% | -13.28% | 1.67B | |
| Average | -3.64% | -2.70% | -16.96% | -12.82% | 4.55B | |
| Weighted average by Cap. | -3.25% | -2.35% | -15.88% | -12.75% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.9M 11.91M 11.14M 10.2M 1.33B 19.39M 132M 51.33M 668M 52.19M 51.05M 2.21B | 22.25M 16.16M 13.84M 12.95M 11.85M 1.55B 22.54M 153M 59.67M 777M 60.67M 59.35M 2.57B |
| Net income | -36.02M -26.16M -22.41M -20.97M -19.19M -2.5B -36.5M -248M -96.61M -1.26B -98.23M -96.09M -4.16B | -126M -91.45M -78.33M -73.29M -67.09M -8.75B -128M -866M -338M -4.4B -343M -336M -14.54B |
| Net Debt | -15.55M -11.29M -9.67M -9.05M -8.29M -1.08B -15.76M -107M -41.7M -543M -42.4M -41.48M -1.8B | 5.22M 3.79M 3.25M 3.04M 2.78M 363M 5.29M 35.91M 14.01M 182M 14.24M 13.93M 603M |
Employees
-
Sector
Pharmaceuticals
